Emcore Corporation  (EMKR)
Other Ticker:  
    Sector  Technology    Industry Semiconductors
   Industry Semiconductors
   Sector  Technology
Price: $1.1500 $0.00 0.000%
Day's High: $1.1783 Week Perf: 2.68 %
Day's Low: $ 1.13 30 Day Perf: -17.86 %
Volume (M): 143 52 Wk High: $ 3.81
Volume (M$): $ 164 52 Wk Avg: $2.17
Open: $1.14 52 Wk Low: $0.86

 Market Capitalization (Millions $) 43
 Shares Outstanding (Millions) 38
 Employees 364
 Revenues (TTM) (Millions $) 124
 Net Income (TTM) (Millions $) -19
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 6

Emcore Corporation

EMCORE Corporation, together with its subsidiaries, was established in 1984 as a New Jersey corporation. The Company became publicly traded in 1997 and is listed on the Nasdaq Stock Exchange under the ticker symbol EMKR. EMCORE pioneered the linear fiber optic transmission technology that enabled the world’s first delivery of Cable TV directly on fiber, and today is a leading provider of advanced Mixed-Signal Optics products that enable communications systems and service providers to meet growing demand for increased bandwidth and connectivity. The Mixed-Signal Optics technology at the heart of our broadband communications products is shared with our fiber optic gyros and inertial sensors to provide the aerospace and defense markets with state-of-the-art navigations systems technology. With both analog and digital circuits on multiple chips, or even a single chip, the value of Mixed-Signal device solutions is often far greater than traditional digital applications and requires a specialized expertise held by EMCORE which is unique in the optics industry.

EMCORE has fully vertically-integrated manufacturing capability through our Indium Phosphide (“InP”) compound semiconductor wafer fabrication facility at our headquarters in Alhambra, CA. The facility supports EMCORE’s vertically-integrated manufacturing for our laser, transmitter and receiver products for Cable TV and other broadband applications, fiber optic gyro sensors for Navigation Systems, and chip devices for Telecom and Datacom applications.

We currently have one reporting segment: Fiber Optics. This segment is comprised of three product lines: Broadband, Chip Devices and Navigation Systems. Please see our consolidated financial statements and footnotes included in this Annual Report for financial information regarding this segment. Until the quarter ended December 31, 2014, we operated as two segments: Fiber Optics and Photovoltaics. EMCORE's former Solar Photovoltaics business, which was sold in December 2014, provided products for space power applications including high-efficiency multi-junction solar cells, covered interconnect cells and complete satellite solar panels. In addition, as further described below, EMCORE sold certain assets, and transferred certain liabilities, of the Company's telecommunications business, including the ITLA (Integrable Tunable Laser Assembly) micro-ITLA, T-TOSA (Tunable Transmitter Optical Subassembly) and T-XFP (Tunable 10 Gigabit Form Factor Pluggable) product lines within the Company’s telecommunications business, in January 2015.

InP compound semiconductor-based products provide the foundation of components, subsystems, and systems used in a broad range of technology markets. Compound semiconductor materials can provide electrical or electro-optical functions, such as emitting optical communications signals and detecting optical communications signals.

Specifically, within our Fiber Optics reporting segment, our Broadband products serve the Cable TV (“CATV”), Satellite Communications and Wireless markets; our Chip products serve the Telecommunications, Fiber-To-The-Premises (“FTTP”), Long-Term Evolution (“LTE”) and Data Center markets; and our Navigation Systems products primarily serve the Aerospace and Defense markets.

   Company Address: 2015 W. Chestnut Street Alhambra 91803 CA
   Company Phone Number: 293-3400   Stock Exchange / Ticker: NASDAQ EMKR
   EMKR is expected to report next financial results on May 04, 2023.

Customers Net Income fell by EMKR's Customers Net Profit Margin fell to

-41.17 %

9.04 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
BHE        4.55% 
IPGP        5.56% 
KE        7.97% 
MXL        0.54% 
OSIS        3.24% 
PLXS        3.18% 
• View Complete Report

Vericity Inc

The Life Insurance company declared that Sales were Soft, during the October to December 31 2022 time-frame

For the financial period ending December 31 2022 company increased a loss per share of $-0.50 per share compare to $-0.26 a year before and grew loss from $-0.34 per share from the preceding reporting period.

Sales declined in double digits by -13.341 % to $41.98 millions from $48.44 millions in the comparable reporting period a year before and sequentially Sales grew by 5.746 % from $39.69 millions.

Vaccinex Inc

The company published Sales of $0.85 millions, in the October to December 31 2022

Vaccinex Inc proclaimed $0.85 millions, in Sales in the most recent fiscal period.

Forte Biosciences Inc

The arising company from the Major Pharmaceutical Preparations market the FBRX released the fourth quarter of 2022 earnings season, results

The shareholders haven't anticipated some adjustments at the business during the the earnings season of the October to December 31 2022 time at the Forte Biosciences Inc . However, stockholders monitor the Major Pharmaceutical Preparations company's operating loss which was at $-4.939 millions, in the same period.

Nuburu Inc

In the fiscal span ending fourth quarter of 2022 operating deficit illustrated progress to $-0.87777 millions, at the BURUWS

Trailing the leaders in the Industrial Machinery and Components industry, a few lesser known businesses are coming in with the numbers. Nuburu Inc mentioned it has clinched operating deficit of $-0.496524 millions, for the fourth quarter of 2022.

Thorne Healthtech Inc

Focusing on the fourth quarter of 2022 the Major Pharmaceutical Preparations company income turned positive at $0.23 per share, relative to the earnings of $-0.01 per share a year ago quarter, In the previous quarter the Thorne Healthtech Inc realized $0.07 per share.


Emcore's Segments
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

CURI's Profile

Stock Price

CURI's Financials

Business Description


Charts & Quotes

CURI's News


CURI's Competitors

Customers & Markets

Economic Indicators

CURI's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries




At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071